EBS icon

Emergent Biosolutions

160 hedge funds and large institutions have $176M invested in Emergent Biosolutions in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

1% less call options, than puts

Call options by funds: $944K | Put options by funds: $956K

47% less capital invested

Capital invested by funds: $332M → $176M (-$156M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
160
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$944K
Puts
$956K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$519K
52
$483K
53
$482K
54
$470K
55
$462K
56
$458K
57
$454K
58
$424K
59
$422K
60
$417K
61
$314K
62
$313K
63
$311K
64
$310K
65
$299K
66
$290K
67
$213K
68
$179K
69
$177K
70
$170K
71
$154K
72
$152K
73
$144K
74
$136K
75
$135K